Tenaya Therapeutics Inc (TNYA) PT Lowered to $24 at Chardan Capital Markets
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall St slumps as sharp tech losses put Nasdaq on course for correction
- Massive market rotation raises question: Is the sell-AI trade here to stay?
- Goldman sees major AI and data center policy implications from ‘blue tsunami’
- Apple seeks to raise up to $7 billion in seven-tranche bond offering
- Nvidia chips stockpile in Hong Kong awaits China import approval - report
Tweet
Share
E-mailGet Alerts TNYA Hot Sheet
Price: $0.36 -2.7%
Rating Summary:
7 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 20 | Down: 37 | New: 6
Rating Summary:
7 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 20 | Down: 37 | New: 6
Join SI Premium – FREE
Chardan Capital Markets analyst Geulah Livshits lowered the price target on Tenaya Therapeutics Inc (NASDAQ: TNYA) to $24.00 (from $28.00) while maintaining a Buy rating.
You May Also Be Interested In
- Tenaya Therapeutics Inc (TNYA) PT Lowered to $6 at Piper Sandler
- Novo Nordisk (NVO) PT Raised to $44 at BMO Capital
- Procore Technologies, Inc (PCOR) PT Raised to $86 at BMO Capital on 'Impressive Execution'
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
